NurExone Biologic (J90) Ownership - Who Owns NurExone Biologic?
4 Followers
NurExone Biologic (J90) Ownership Overview
- 0.22% Insiders
- 99.78% Public Companies and Individual Investors
The ownership structure of NurExone Biologic (DE:J90) stock is a mix of institutional, retail, and individual investors. , 0.22% is owned by Insiders, and 99.78% is owned by Public Companies and Individual Investors.
The ownership structure of NurExone Biologic (DE:J90) stock is a mix of institutional, retail, and individual investors. , 0.22% is owned by Insiders, and 99.78% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Dec 22, 2025 | James Angus Wilson Richardson | C$6,800 | |
| Dec 01, 2025 | James Angus Wilson Richardson | C$3,450 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| James Angus Wilson Richardson | 168,274 | Insider | 0.22% | 54,016 |
FAQ
What percentage of NurExone Biologic (DE:J90) stock is held by retail investors?
According to the latest TipRanks data, approximately 99.78% of NurExone Biologic (DE:J90) stock is held by public companies and individual investors.
Who owns the most shares of NurExone Biologic (DE:J90)?
James Angus Wilson Richardson owns the most shares of NurExone Biologic (DE:J90).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
